Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count

INTRODUCTION: Recently published large randomized controlled trials, START, TEMPRANO and HPTN 052 show the clinical benefit of early initiation of antiretroviral treatment (ART) in HIV-infected persons and in reducing HIV transmission. The trials influenced the World Health Organization (WHO) decisi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bigna, Jean Joel R., Plottel, Claudia S., Koulla-Shiro, Sinata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011352/
https://www.ncbi.nlm.nih.gov/pubmed/27593965
http://dx.doi.org/10.1186/s40249-016-0179-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011352/
https://www.ncbi.nlm.nih.gov/pubmed/27593965
http://dx.doi.org/10.1186/s40249-016-0179-9

Ejemplares similares